Trillium Therapeutics Announces Proposed Public Offering of Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
UPDATE: Trillium Therapeutics (TRIL) Prices 1.52M Common Offering at $19.50/Share
April 1, 2015 7:01 AM EDT(Updated - April 1, 2015 7:03 AM EDT)
Trillium Therapeutics (NASDAQ: TRIL) has priced a 1.52 million common stock offering at $19.50 per share.
UPDATE - The press release and SEC filing follow:
Trillium Therapeutics announced that it has priced an underwritten public offering of 1,522,395 common... More
Trillium Therapeutics (TRIL) Announces $50M Common Stock Offering
March 30, 2015 4:03 PM EDTTrillium Therapeutics (NASDAQ: TRIL) announced that it is offering to sell US$50,000,000 of common shares and preferred shares in an underwritten public offering. The preferred shares are being offered to certain of Trillium's existing shareholders whose purchase of common shares in this offering may... More
